Skip to main content Skip to section navigation Skip to footer
Investor Relations
Back to heartbeam.com

HeartBeam, Inc.

Investor Relations
  • Investors
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Media
    • Media Archive
  • Company Info
    • Overview
    • Leadership
      • Management Team
      • Scientific Advisory Board
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

IR Calendar

News & Events

News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
  • Media
  • Media Archive

Fourth Quarter 2025 Earnings Conference Call

Mar 12, 2026 4:30 pm EDT
Earnings Release
PDF HTML
Earnings Webcast
Audio
Earnings Presentation
PDF
10-K Filing
PDF HTML
XBRL
ZIP HTML
  • Email Alerts
  • Contacts
  • RSS News Feed

The HeartBeam System is a portable non-invasive recorder intended to record, store, and transfer a patient’s 3-Lead (in three-directions) electrocardiogram (ECG) acquired from 5 electrodes. The device is intended to be used by adult patients in either a clinical setting or at home. The device does not conduct cardiac analysis and can be used with an ECG Viewer software system for manual interpretation of non-life-threatening arrhythmias by a physician or healthcare professional.

The HeartBeam 12-Lead ECG Synthesis Software synthesizes a 12-Lead ECG from the HeartBeam System 3-Leads (in three-directions) recording device, producing a visual 12-Lead ECG representation that is similar, but not identical, to the same leads of a standard diagnostic 12-Lead ECG. The synthesized 12-Lead ECG output is solely intended for manual assessment of normal sinus rhythm and the following non-life-threatening arrhythmias: sinus arrhythmia, sinus tachycardia, sinus bradycardia, atrial premature complexes, atrial fibrillation, and ventricular premature complex. The synthesized 12-Lead ECG output is not intended for the assessment of any other arrhythmia or conditions (including but not limited to: other atrial arrhythmias, ventricular arrhythmias, hypertrophy, conduction disorders, myocardial infarction or ischemia, pacemaker functions, localization of arrhythmia foci, ECG wave abnormalities, and/or any other disorder). The software does not conduct cardiac analysis and is not intended to replace a standard 12-Lead ECG. The 12-Lead ECG Synthesis Software is intended for adult use only. For full safety information, see the full Instructions for Use or Clinician Portal Manual.

© 2026 HeartBeam, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap